CONTENTS
Assistant Editor
Special Assignments
julia aalbers
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Fax: 086 628 1197
e-mail:
Editorial Assistant &
Circulation
ELSABÉ BURMEISTER
Tel: 021 976 8129
e-mail:
Production
Co-ordinator
WENDY WEGENER
Tel: (021) 976-4378
e-mail:
GAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail :
Editorial BOARD
The
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
, is published six
times a year, the deemed publication
date being the seventh day of the
second designated month,
i.e. 7 February, 7 April, 7 June, 7
August and 7 October.
Copyright:
Clinics Cardive Publishing, Pty, Ltd.
Layout:
Martingraphix
Printer:
Durbanville Commercial Printers
All submissions to CVJA are to be
made online via
Electronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, 7551
Tel/Fax: 021 976 8129
Int.: +27 21 976 8129
e-mail:
Electronic abstracts available on
Pubmed
Audited circulation
Full text articles available on:
or via
co.za; for access codes contact
User ID: cvja8
Password: cvja8
Subscriptions for six issues:
South Africa: R300 (excl VAT)
Other African countries: $30
Overseas: Institutions: R845 ($82)
Individuals: R1 080 ($105)
The views and opinions expressed
in the articles and reviews published
are those of the authors and do not
necessarily reflect those of the editors
of the Journal or its sponsors. In all
clinical instances, medical practitioners
are referred to the product insert
documentation as approved by the
relevant control authorities.
VOL 21, NO 5. SEPTEMBER / OCTOBER 2010
Review Article
280 The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives
PMO Owira • JAO Ojewole
Case Report
286 Congenital absence of the left circumflex coronary artery and an unusually dominant
course of the right coronary artery
M Baskurt • B Okcun • IM Caglar • AA Ozkan • M Ersanli • T Gurmen
Your Life and Your Heart
289 Update on smoking cessation techniques
J Aalbers
Special Report
291 Reaching target LDL cholesterol has become more affordable with launch of ezetimibe/
simvastatin combination in South Africa
J Aalbers
Drug Trends
295 Osteoporosis: a cardiovascular risk factor equivalent to type 2 diabetes
P Wagenaar
296 Focus on 2010 South African Heart Congress
Dangers of switching anti-hypertension medication
J Aalbers
The J-shaped curve: fact or fiction?
Anti-thrombotic trials in atrial fibrillation, the
RELY study
J Aalbers
300 Focus on 2010 ESC
New ESC guidelines and data on dabigatran
J Aalbers
Effective single-drug approach is welcomed
for deep-vein thrombosis treatment
SHIFTING the burden of heart failure
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
